Cancer Drugs Market by Therapy (Immunotherapy, Targeted Therapy, Chemotherapy, Hormone Therapy and Others) for Breast Cancer, Blood Cancer, Gastrointestinal Cancer, Prostate Cancer, Skin Cancer, Lung Cancer and Other Cancer: Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 - 2021

Global cancer drugs market is expected to reach USD 161.30 billion by end of 2021, growing at a CAGR of around 7.4% between 2016 and 2021.

07-Dec-2016 | Number of pages: 110 | Report Code: ZMR-490 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the cancer drugs market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based revenue (USD Billion). The study includes drivers and restraints for the cancer drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cancer drugs market on a global level.

In order to give the users of this report a comprehensive view on the cancer drugs market, we have include competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein Therapy segments and cancer type segments are benchmarked based on their market size, growth rate and general attractiveness.

The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new Therapy launch, agreements, partnerships, collaborations & joint ventures, research& development, Therapy and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, Therapy portfolio of various companies along with patent analysis (2011-2016) bifurcated into the patent trend, patent share by company and patent analysis according to the region.

The study provides a decisive view on the cancer drugs market by segmenting the market based on therapy, cancer type, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. Based on therapy the market is segmented into immunotherapy, targeted therapy, chemotherapy, hormone therapy and others. Key cancer type covered under this study includes breast cancer, blood cancer, gastrointestinal cancer, prostate cancer, skin cancer, lung cancer and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America and the Middle East & Africa with its further bifurcation into major countries including the U.S. Germany, France, UK, China, Japan, India, and Brazil. This segmentation includes demand for cancer drugs based on individual therapy and cancer in all the regions and countries.

The report also includes detailed profiles of end players such as Bayer, GlaxoSmithKline, Novartis, Sanofi and Pfizer, Amgen, Merck, Bristol-Myers Squibb, Celgene Corporation, Ariad Pharmaceuticals, Eli Lilly, Hoffmann-La Roche Ltd, Boehringer Ingelheim GmbH, Johnson and Johnson and Teva Pharmaceuticals among others.

This report segments the global cancer drugs market as follows:

Global Cancer Drugs Market: Therapy Segment Analysis

  • Immunotherapy
  • Targeted Therapy
  • Chemotherapy
  • Hormone Therapy
  • Others

Global Cancer Drugs Market: Cancer Type Segment Analysis.

  • Breast Cancer
  • Blood Cancer
  • Gastrointestinal Cancer
  • Prostate Cancer
  • Skin Cancer
  • Lung Cancer
  • Others

Global Cancer Drugs Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Related Reports

Transport System Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1772 | Report Format:

Transport System Market: Overview Being a division of planning and execution system, transport system provides solutions that aid companies to complete operations in a more reliable, efficient, and cost-effective way. TMS can also be called as a part of resource management and supply chain manag...Read More

Healthcare IT Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1764 | Report Format:

Global Healthcare IT Market: Overview Healthcare information technology is used to manage, control, and automate various tasks and processes in the healthcare organizations. Use of sophisticated technologies will offer efficient patient-centric approach along with restricted adverse impacts asso...Read More

Human Identification Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1714 | Report Format:

Global Human Identification Market: Overview Forensic identification comes under forensic science; it is a technology which helps in the identification of the traces that are left out at the place where there occurs an accident or crime. Human identification techniques are extensively used in th...Read More

Microplate Readers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1650 | Report Format:

Global Microplate Readers Market: Overview A laboratory instrument that is designed for detection and processing the chemical, biological, or physical reactions for experimental purposes is known as microplate readers. It is helpful in the gene expression, quantification of proteins, and testing...Read More

Bioprocess Technology Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-1560 | Report Format:

Global Bioprocess Technology Market: Overview The bioprocess technology plays a very vital role in the biotechnology industry. Desired products are procured in a bioprocess from the cells that are alive such as enzymes, bacteria, and chloroplast or their components. The bioprocess is leveraged i...Read More

Choose License Type: